CDSCO mandates batch-wise NDMA testing in ranitidine, urges expiry cuts, storage reviews, and launches expert study amid cancer risk concerns linked to the antacid's long-term safety.
The Central Drugs Standard Control Organisation (CDSCO) has released a list of 17 medicines deemed especially harmful, advising the public to flush them to prevent misuse and environmental hazards